Here’s how Eli Lilly is fixing its Zepbound supply shortage
Zepbound is typically sold in auto-injector pens, but with vials Lilly will eliminate that step and be able to get the drug to patients more quickly.
Eli Lilly said it has begun selling vials of the smallest, starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month on its direct-to-consumer website to try to increase supplies in the marketplace.